Impact of Discrepancies between the Abbott RealTime and Cobas TaqMan Assays for Quantification of Human Immunodeficiency Virus Type 1 Group M Non-B Subtypes-Reference-Cited by-同舟云学术

Impact of Discrepancies between the Abbott RealTime and Cobas TaqMan Assays for Quantification of Human Immunodeficiency Virus Type 1 Group M Non-B Subtypes

Published:2009-05 Issue:5 Volume:47 Page:1543-1545
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Wirden M.¹²,Tubiana R.²³,Marguet F.³,Leroy I.¹,Simon A.⁴,Bonmarchand M.⁴,Ait-Arkoub Z.¹,Murphy R.³,Marcelin A. G.¹²,Katlama C.²³,Calvez V.¹²

Affiliation:

1. Department of Virology, Pitié-Salpêtriere Hospital, Paris, France

2. Inserm U943, Paris, France

3. Department of Infectious Diseases, Pitié-Salpêtriere Hospital, Paris, France

4. Department of Internal Medicine, Pitié-Salpêtrière Hospital, Paris, France

Abstract

ABSTRACT Viral loads in 249 clinical samples from individual patients infected with human immunodeficiency virus type 1 non-B subtypes were determined with both the Abbott RealTime and Cobas TaqMan assays. The differences exceeded 0.5 log for about 20% of samples and 1 log for 3%, with higher values always from the Abbott assay in the latter cases.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.02134-08

Reference10 articles.

1. Braun, P., R. Ehret, F. Wiesmann, F. Zabbai, M. Knickmann, R. Kuhn, S. Thamm, G. Warnat, and H. Knechten. 2007. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. Clin. Chem. Lab. Med.45:93-99.

2. Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Assays

3. Descamps, D., M. L. Chaix, P. Andre, V. Brodard, J. Cottalorda, C. Deveau, M. Harzic, D. Ingrand, J. Izopet, E. Kohli, B. Masquelier, S. Mouajjah, P. Palmer, I. Pellegrin, J. C. Plantier, C. Poggi, S. Rogez, A. Ruffault, V. Schneider, A. Signori-Schmuck, C. Tamalet, M. Wirden, C. Rouzioux, F. Brun-Vezinet, L. Meyer, and D. Costagliola. 2005. French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002. J. Acquir. Immune Defic. Syndr.38:545-552.

4. Evaluation of the Roche Cobas TaqMan and Abbott RealTime Extraction-Quantification Systems for HIV-1 Subtypes

5. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the ELITechGroup solution for plasma HIV-1 RNA quantification;Journal of Clinical Virology;2024-08

2. Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains;Journal of Clinical Virology;2019-01

3. Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load;Journal of Clinical Virology;2017-11

4. Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0–HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants;Journal of Clinical Virology;2015-10

5. Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV-1 RNA Viral Load in Abuja, Nigeria;Current HIV Research;2015-06-15